Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.
BACKGROUND
The aim of this study was to evaluate associations of clinical features, such as hirsutism, polycystic ovaries (PCOs), ovulatory dysfunction, and body mass index (BMI) > or =25 kg/m(2), with metabolic abnormalities in hyperandrogenic women.


METHODS
Hirsutism was based on the modified Ferriman-Gallwey score. Ovulatory function was classified as eumenorrhea, oligomenorrhea and amenorrhea, and PCOs were assessed using the ultrasound criteria recommended in the Rotterdam definition. An oral glucose tolerance test was performed. Different insulin resistance (IR) indices were calculated.


RESULTS
Hirsute women had significantly higher BMI, DHEA sulfate (DHEAS) and free androgen index (FAI), and significantly lower values for sex hormone-binding globulin (SHBG). Women with amenorrhea were younger in comparison to women with eumenorrhea and had significantly higher values for fasting insulin (FI) and 1- and 2-h insulin levels; lower values for glucose to insulin ratio (GIR), quantitative insulin sensitivity check index (QUICKI), and SHBG. Women with PCO had significantly higher levels of LH and low-density lipoprotein (LDL), whereas high-density lipoprotein (HDL) levels were significantly lower. Women with a BMI > or =25 kg/m(2) had significantly higher values for age, fasting plasma glucose, FI, and 1- and 2-h glucose and insulin levels, homeostatic model for assessment of IR (HOMA-IR), homeostatic model for assessment of B-cell function (HOMA-B), and FAI, whereas their GIR, insulin sensitivity index, QUICKI, SHBG, and HDL were significantly lower.


CONCLUSIONS
In women with hyperandrogenic syndrome, BMI> or =25 kg/m(2) and amenorrhea appear to be associated with severe endocrine and metabolic abnormalities.
Cupisti
S
S
Department of Obstetrics and Gynecology, Erlangen University Hospital, Universitaetsstrasse 21-23, D-91054 Erlangen, Germany.
Kajaia
N
N
Dittrich
R
R
Duezenli
H
H
W Beckmann
M
M
Mueller
A
A
D000328:Adult; D000568:Amenorrhea / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D000704:Analysis of Variance; D000728:Androgens / Q000097:blood; D001786:Blood Glucose; D015992:Body Mass Index; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D006628:Hirsutism / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D017588:Hyperandrogenism / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008598:Menstruation; D015999:Multivariate Analysis; D010053:Ovary / Q000502:physiology*; D050177:Overweight / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D012720:Severity of Illness Index; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism
D000728:Androgens; D001786:Blood Glucose; D007328:Insulin; D012738:Sex Hormone-Binding Globulin; D019314:Dehydroepiandrosterone Sulfate